These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 26550561)
1. Evidence of Mitochondrial Dysfunction within the Complex Genetic Etiology of Schizophrenia. Hjelm BE; Rollins B; Mamdani F; Lauterborn JC; Kirov G; Lynch G; Gall CM; Sequeira A; Vawter MP Mol Neuropsychiatry; 2015 Dec; 1(4):201-19. PubMed ID: 26550561 [TBL] [Abstract][Full Text] [Related]
2. Novel Complex Interactions between Mitochondrial and Nuclear DNA in Schizophrenia and Bipolar Disorder. Schulmann A; Ryu E; Goncalves V; Rollins B; Christiansen M; Frye MA; Biernacka J; Vawter MP Mol Neuropsychiatry; 2019 Mar; 5(1):13-27. PubMed ID: 31019915 [TBL] [Abstract][Full Text] [Related]
3. Loss of Microtubule-Associated Protein 2 Immunoreactivity Linked to Dendritic Spine Loss in Schizophrenia. Shelton MA; Newman JT; Gu H; Sampson AR; Fish KN; MacDonald ML; Moyer CE; DiBitetto JV; Dorph-Petersen KA; Penzes P; Lewis DA; Sweet RA Biol Psychiatry; 2015 Sep; 78(6):374-85. PubMed ID: 25818630 [TBL] [Abstract][Full Text] [Related]
4. Psychiatric drugs impact mitochondrial function in brain and other tissues. Chan ST; McCarthy MJ; Vawter MP Schizophr Res; 2020 Mar; 217():136-147. PubMed ID: 31744750 [TBL] [Abstract][Full Text] [Related]
5. DNA methylation as a putative mechanism for reduced dendritic spine density in the superior temporal gyrus of subjects with schizophrenia. McKinney B; Ding Y; Lewis DA; Sweet RA Transl Psychiatry; 2017 Feb; 7(2):e1032. PubMed ID: 28195572 [TBL] [Abstract][Full Text] [Related]
6. Mitochondrial Complex I Deficiency in Schizophrenia and Bipolar Disorder and Medication Influence. Rollins BL; Morgan L; Hjelm BE; Sequeira A; Schatzberg AF; Barchas JD; Lee FS; Myers RM; Watson SJ; Akil H; Potkin SG; Bunney WE; Vawter MP Mol Neuropsychiatry; 2018 Feb; 3(3):157-169. PubMed ID: 29594135 [TBL] [Abstract][Full Text] [Related]
7. Investigation of de novo mutations in a schizophrenia case-parent trio by induced pluripotent stem cell-based in vitro disease modeling: convergence of schizophrenia- and autism-related cellular phenotypes. Hathy E; Szabó E; Varga N; Erdei Z; Tordai C; Czehlár B; Baradits M; Jezsó B; Koller J; Nagy L; Molnár MJ; Homolya L; Nemoda Z; Apáti Á; Réthelyi JM Stem Cell Res Ther; 2020 Nov; 11(1):504. PubMed ID: 33246498 [TBL] [Abstract][Full Text] [Related]
8. Current advancements of modelling schizophrenia using patient-derived induced pluripotent stem cells. Dubonyte U; Asenjo-Martinez A; Werge T; Lage K; Kirkeby A Acta Neuropathol Commun; 2022 Dec; 10(1):183. PubMed ID: 36527106 [TBL] [Abstract][Full Text] [Related]
9. Morphological and transcriptomic analyses of stem cell-derived cortical neurons reveal mechanisms underlying synaptic dysfunction in schizophrenia. Kathuria A; Lopez-Lengowski K; Watmuff B; Karmacharya R Genome Med; 2023 Jul; 15(1):58. PubMed ID: 37507766 [TBL] [Abstract][Full Text] [Related]
10. Isolated Mitochondria Transfer Improves Neuronal Differentiation of Schizophrenia-Derived Induced Pluripotent Stem Cells and Rescues Deficits in a Rat Model of the Disorder. Robicsek O; Ene HM; Karry R; Ytzhaki O; Asor E; McPhie D; Cohen BM; Ben-Yehuda R; Weiner I; Ben-Shachar D Schizophr Bull; 2018 Feb; 44(2):432-442. PubMed ID: 28586483 [TBL] [Abstract][Full Text] [Related]
11. GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Guidotti A; Auta J; Davis JM; Dong E; Grayson DR; Veldic M; Zhang X; Costa E Psychopharmacology (Berl); 2005 Jul; 180(2):191-205. PubMed ID: 15864560 [TBL] [Abstract][Full Text] [Related]